# Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

> **NCT04397302** · — · COMPLETED · sponsor: **Italian Society of Cardiology** · enrollment: 652 (actual)

## Conditions studied

- Heart Failure, Left Sided
- Left Ventricular Dysfunction
- Ventricular Remodeling

## Interventions

- **DIAGNOSTIC_TEST:** Role of Sacubitril/Valsartan in Hemodynamic and Echocardiographic Improvement of Heart Failure With Reduced Ejection Fraction

## Key facts

- **NCT ID:** NCT04397302
- **Lead sponsor:** Italian Society of Cardiology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-13
- **Primary completion:** 2020-03-16
- **Final completion:** 2020-03-16
- **Target enrollment:** 652 (ACTUAL)
- **Last updated:** 2020-05-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397302, "Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04397302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*